EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
19 hedge funds and large institutions have $38.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$114K |
2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$47 |
Top Sellers
1 |
ACM
Altium Capital Management
New York
|
-$4.01M |
2 |
KCM
Kingdon Capital Management
New York
|
-$2.01M |
3 |
HM
HealthCor Management
New York
|
-$1.02M |
4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$571K |
5 |
MS
Maven Securities
St Helier,
Jersey
|
-$331K |